Legislation designed to help contain costs and promote safe and effective use of clinically proven prescription drugs has been proposed for the state of Washington, but was not enacted in 2002. This random telephone survey of 1,006 Washingtonians age 18 and over examines reactions to three components of the Rx in Action legislation - bulk purchasing by the State, a preferred drug guide, and an assistance program for consumers without adequate prescription drug coverage. It also explores financial hardships associated with paying for prescription drugs, and cost containment practices now utilized by consumers.
Interviews were conducted between November 1 and 11, 2002 by Southeastern Institute of Research, Inc. The report was prepared by Debbie Gann of AARP Knowledge Management. For more information, please contact Jennifer Sauer at 202-434-6207. (27 pages)